|1 Table of Contents 3
|1.1 List of Tables 6
|1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Aesthetic Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Aesthetic Devices Market, China 15
3.1 Aesthetic Devices Market, China, Revenue ($m), 2018-2033 15
3.2 Aesthetic Devices Market, China, Revenue Mix ($m), 2023 17
3.3 Aesthetic Devices Market, China, Category Contribution by Revenue ($m), 2023 18
3.4 Aesthetic Devices Market, China, Revenue ($m), 2018-2033 20
3.5 Aesthetic Devices Market, China, Volume (Units), 2018-2033 22
3.6 Aesthetic Devices Market, China, Volume (Units), 2018-2033 24
3.7 Aesthetic Devices Market, China, Company Share by Revenue ($m), 2023 27
4 Aesthetic Implants Market, China 29
4.1 Aesthetic Implants Market, China, Revenue Mix ($m), 2023 29
4.2 Aesthetic Implants Market, China, Segment Contribution (%), 2023 30
4.3 Aesthetic Implants Market, China, Revenue ($m), 2018-2033 32
4.3.1 Breast Implants Market, China, Revenue ($m), by Segment, 2018-2033 34
4.3.2 Face Implants Market, China, Revenue ($m), by Segment, 2018-2033 36
4.3.3 Penile Implants Market, China, Revenue ($m), by Segment, 2018-2033 38
4.4 Aesthetic Implants Market, China, Volume (Units), 2018-2033 40
4.4.1 Breast Implants Market, China, Volume (Units), by Segment, 2018-2033 42
4.4.2 Face Implants Market, China, Volume (Units), by Segment, 2018-2033 44
4.4.3 Penile Implants Market, China, Volume (Units), by Segment, 2018-2033 46
4.5 Aesthetic Implants Market, China, Average Price ($), 2018-2033 48
4.6 Aesthetic Implants Market, China, Distribution Share by Revenue ($m), 2018-2033 50
4.7 Aesthetic Implants Market, China, Company Share by Revenue ($m), 2023 51
5 Aesthetic Injectables Market, China 53
5.1 Aesthetic Injectables Market, China, Revenue Mix ($m), 2023 53
5.2 Aesthetic Injectables Market, China, Segment Contribution (%), 2023 54
5.3 Aesthetic Injectables Market, China, Revenue ($m), 2018-2033 56
5.3.1 Hyaluronic Acid Fillers Market, China, Revenue ($m), by Segment, 2018-2033 58
5.3.2 Non Hyaluronic Acid Fillers Market, China, Revenue ($m), by Segment, 2018-2033 60
5.4 Aesthetic Injectables Market, China, Volume (Units), 2018-2033 62
5.4.1 Hyaluronic Acid Fillers Market, China, Volume (Units), by Segment, 2018-2033 65
5.4.2 Non Hyaluronic Acid Fillers Market, China, Volume (Units), by Segment, 2018-2033 67
5.5 Aesthetic Injectables Market, China, Average Price ($), 2018-2033 69
5.6 Aesthetic Injectables Market, China, Distribution Share by Revenue ($m), 2018-2033 70
5.7 Aesthetic Injectables Market, China, Company Share by Revenue ($m), 2023 71
6 Body Contouring Devices Market, China 73
6.1 Body Contouring Devices Market, China, Revenue Mix ($m), 2023 73
6.2 Body Contouring Devices Market, China, Segment Contribution (%), 2023 74
6.3 Body Contouring Devices Market, China, Revenue ($m), 2018-2033 76
6.3.1 Minimally Invasive Body Contouring Devices Market, China, Revenue ($m), by Segment, 2018-2033 78
6.3.2 Non Invasive Body Contouring Devices Market, China, Revenue ($m), by Segment, 2018-2033 80
6.4 Body Contouring Devices Market, China, Volume (Units), 2018-2033 82
6.4.1 Minimally Invasive Body Contouring Devices Market, China, Volume (Units), by Segment, 2018-2033 84
6.4.2 Non Invasive Body Contouring Devices Market, China, Volume (Units), by Segment, 2018-2033 86
6.5 Body Contouring Devices Market, China, Average Price ($), 2018-2033 88
6.6 Body Contouring Devices Market, China, Distribution Share by Revenue ($m), 2018-2033 90
6.7 Body Contouring Devices Market, China, Company Share by Revenue ($m), 2023 91
7 Laser Resurfacing Devices Market, China 93
7.1 Laser Resurfacing Devices Market, China, Revenue Mix ($m), 2023 93
7.2 Laser Resurfacing Devices Market, China, Segment Contribution (%), 2023 94
7.3 Laser Resurfacing Devices Market, China, Revenue ($m), 2018-2033 96
7.3.1 Multi Technology Combination Laser Devices Market, China, Revenue ($m), by Segment, 2018-2033 98
7.3.2 Single Technology Laser Devices Market, China, Revenue ($m), by Segment, 2018-2033 100
7.4 Laser Resurfacing Devices Market, China, Volume (Units), 2018-2033 102
7.4.1 Multi Technology Combination Laser Devices Market, China, Volume (Units), by Segment, 2018-2033 104
7.4.2 Single Technology Laser Devices Market, China, Volume (Units), by Segment, 2018-2033 106
7.5 Laser Resurfacing Devices Market, China, Average Price ($), 2018-2033 108
7.6 Laser Resurfacing Devices Market, China, Distribution Share by Revenue ($m), 2018-2033 109
7.7 Laser Resurfacing Devices Market, China, Company Share by Revenue ($m), 2023 110
8 Overview of Key Companies in China, Aesthetic Devices Market 112
8.1 Galderma SA 112
8.1.1 Company Overview 112
8.2 Allergan Aesthetics 112
8.2.1 Company Overview 112
8.3 Mentor Worldwide LLC 112
8.3.1 Company Overview 112
8.4 Cynosure Inc 112
8.4.1 Company Overview 112
8.5 Lutronic Corp 113
8.5.1 Company Overview 113
8.6 Candela Corp 113
8.6.1 Company Overview 113
8.7 Guangzhou Wanhe Plastic Materials Co Ltd 113
8.7.1 Company Overview 113
8.8 Merz Pharma GmbH & Co KgaA 113
8.8.1 Company Overview 113
9 Aesthetic Devices Market Pipeline Products 114
10 Financial Deals Landscape 115
10.1 Acquisition 115
10.1.1 Wu Zhong Meixiu Invests USD4.13 Million in Beijing Li Lai Technology 115
10.2 Equity Offerings 116
10.2.1 Pheton Holdings (Beijing Feitian Zhaoye Technology) Raises USD9 Million in Initial Public Offering (IPO) of Shares 116
10.3 Venture Financing 118
10.3.1 Mil Medical Technology Shenzhen (Mir Medical, Mill Medical) Raises Funds through Venture Financing 118
10.3.2 Shenzhen Myway Medical Technology (Myvi Medical, Shenzhen Maiwei Medical Technology) Secures USD14.01 Million in Series A Financing 120
10.3.3 Guangzhou Xinzhu Medical Technology (Xinzhu Medical) Secures Funds in Pre-Series A Financing 121
10.3.4 Suzhou Baifu Laser Technology (Nanjing Baifu) Raises Funds through Series B Financing 122
11 Recent Developments 123
11.1 Financial Announcements 123
11.1.1 Aug 27, 2024: Beauty Farm Medical and Health Industry Announces Interim Results for the Six Months Ended June 30, 2024 123
11.2 Legal And Regulatory 123
11.2.1 Mar 18, 2025: Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance 123
11.3 Other Significant Developments 123
11.3.1 Sep 25, 2024: Bloomage's Pioneering Pilot-Scale Testing Platform Now Fully Operational, Ushering in New Era of Open Innovation 123
11.4 Product News 124
11.4.1 Mar 03, 2025: Raziel and Fosun Pharma (by JuveStar an affiliate company of Fosun Pharma) Initiate Phase 3 Registration Trial in China for Submental Fat Reduction ("Double Chin") 124
11.4.2 Jun 25, 2024: Singclean: Unveiled Singfiller and Singderm in IMCAS ASIA 2024, Poised for Thailand's Big Launch 125
11.4.3 Jun 24, 2024: Wingderm Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions 125
11.5 Strategy And Business Planning 126
11.5.1 Apr 16, 2024: Wingderm Shines Bright in the U.S.A. Continuously Expanding the Local Business Network 126
12 Appendix 127
12.1 Research Methodology 128
12.1.1 Coverage 128
12.1.2 Secondary Research 128
12.1.3 Primary Research 129
12.1.4 Market Modeling and Forecasting 129
12.1.5 Company Share Analysis 131
12.1.6 Distribution Share Analysis 131
12.1.7 Benchmarking 131
12.2 GlobalData Consulting 132
12.3 Contact Us 132
12.4 Disclaimer 132